A retrospective cohort study of comparative effectiveness of BNT162b2 and mRNA-1273 booster dose using data from registry systems for vaccination and COVID-19 infection
Latest Information Update: 23 Sep 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 23 Sep 2022 New trial record
- 18 Sep 2022 Results published in the Clinical Infectious Diseases